Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Eray Gökkurt"'
Autor:
Joseph Tintelnot, Alexander Stein, Salah-Eddin Al-Batran, Thomas Ettrich, Thorsten Götze, Barbara Grün, Georg Martin Haag, Vera Heuer, Ralf-Dieter Hofheinz, Nils Homann, Tobias Sebastian Bröring, Mariana Santos Cruz, Annika Kurreck, Sylvie Lorenzen, Nicolas Moosmann, Christian Müller, Markus Schuler, Gabriele Siegler, Mascha Binder, Eray Gökkurt
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundEsophagogastric adenocarcinoma (EGA) presents a substantial global health challenge as the number of cases continues to rise. The current standard approach for treating localized EGA involves a combination of triplet chemotherapy, which con
Externí odkaz:
https://doaj.org/article/9aca2f640fe447fba35289be96b705be
Autor:
Thomas J Ettrich, Barbara Seliger, Chiara Massa, Alexander Stein, Claudia Wickenhauser, Axel Hinke, Uwe Pelzer, Carsten Bokemeyer, Marcus Bauer, Susanna Hegewisch-Becker, Donjete Simnica, Christoph Schultheiß, Rebekka Scholz, Joseph Tintelnot, Eray Gökkurt, Lisa von Wenserski, Edith Willscher, Lisa Paschold, Markus Sauer, Sylvie Lorenzen, Jorge Riera-Knorrenschild, Reinhard Depenbusch, Steffen Dörfel, Salah-Eddin Al-Batran, Meinolf Karthaus, Lisa Waberer, Mascha Binder
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background In patients with microsatellite stable (MSS) metastatic colorectal cancer (mCRC), immune checkpoint blockade is ineffective, and combinatorial approaches enhancing immunogenicity need exploration.Methods We treated 43 patients with predomi
Externí odkaz:
https://doaj.org/article/5d88a304ea0e44abaa1cca6a22c6374b
Autor:
Sylvie Lorenzen, Gertraud Stocker, Markus Möhler, Thorsten Oliver Götze, Alexander Stein, Eray Gökkurt, Georg Martin Haag, Salah-E. Albatran, Ralf Hofheinz, Nils Homann, Harald Schmalenberg, Michael K. Stahl, Kathrin Heinrich, Stefan Mönig, Peter Thuss-Patience
Publikováno v:
Der Onkologe. 28:23-29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e843448563e2bc49dfa768a9b4ebea5
https://doi.org/10.1007/s00761-021-01087-3
https://doi.org/10.1007/s00761-021-01087-3
Autor:
Sylvie Lorenzen, Peter Thuss-Patience, Claudia Pauligk, Eray Gökkurt, Thomas Ettrich, Florian Lordick, Michael Stahl, Peter Reichardt, Martin Sökler, Daniel Pink, Stefan Probst, Axel Hinke, Thorsten O. Goetze, Salah E. Al-Batran
Publikováno v:
European journal of cancer (Oxford, England : 1990). 165
Ramucirumab and paclitaxel is the standard second-line therapy in patients with metastatic gastroesophageal adenocarcinoma. We report the efficacy and safety analyses of FOLFIRI and ramucirumab versus paclitaxel and ramucirumab after the failure of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba3e3ca51b601f98493eed3f14c5c6de
https://pubmed.ncbi.nlm.nih.gov/35202974
https://pubmed.ncbi.nlm.nih.gov/35202974
Publikováno v:
Der Onkologe. 28:2-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12fc4ebba452b040fc2614028c0cf823
https://doi.org/10.1007/s00761-022-01103-0
https://doi.org/10.1007/s00761-022-01103-0
Autor:
Djordje Atanackovic, Tim H. Brümmendorf, Lucia Vankann, Markus Ertmer, Eray Gökkurt, Jens Panse, Stefan Wilop
Publikováno v:
Blood. 120:4969-4969
Abstract 4969 Introduction: While multiparameter flow cytometry (MPF) is an integral part in the diagnosis, disease staging and response evaluation for hematologic malignancies such as acute leukemia or non-hodgkin-lymphoma, MPF for multiple myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d94c5093563385ef244ec4f3497deb3
https://doi.org/10.1182/blood.v120.21.4969.4969
https://doi.org/10.1182/blood.v120.21.4969.4969
Autor:
Eva Maria Murga Penas, Georgia Schilling, Jakob Matschke, Lisa Billecke, Merav Leiba, Eray Gökkurt, Markus Tiemann, Arnon Nagler, Annette M. May, Andreas H. Marx, Jozef Zustin, Nicolaus Kröger, Carsten Bokemeyer, Monika Engelhardt
Publikováno v:
Blood. 116:4993-4993
Abstract 4993 Introduction: Extramedullary organ impairment in patients with multiple myeloma (MM) is a very rare event, mostly occurring during disease relapse after high-dose chemotherapy with autologous or allogeneic stem cell transplantation. Rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a17d4335fd14d197096ce032f1bcb438
https://doi.org/10.1182/blood.v116.21.4993.4993
https://doi.org/10.1182/blood.v116.21.4993.4993